The US president Donald Trump announced a sweeping tariff plan on 2 April, targeting almost all goods and US trading partners across the globe. However, it appears that pharmaceuticals are one of the few products exempt from these tariffs.
Richard Harrington, a former member of the UK parliament and current member of the House of Lords, said during a 3 April industry conference that “the truth is, nobody knows...